This investigation used shRNA silencing of BMAL1 and CLOCK, or pharmacological suppression of BMAL1 transcription, to disturb the integrity of the circadian rhythms in both murine and human AML cells, resulting in myeloid differentiation and impaired cell cycle progression. This evidence concerns the gene CLOCK and acute myeloid leukemia.